These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8492948)
21. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico. Philen RM; Hill RH; Flanders WD; Caudill SP; Needham L; Sewell L; Sampson EJ; Falk H; Kilbourne EM Am J Epidemiol; 1993 Aug; 138(3):154-9. PubMed ID: 8356958 [TBL] [Abstract][Full Text] [Related]
22. [Polyneuropathy and fasciitis in eosinophilia-myalgia syndrome]. Hetzel W; Dangel P; Molitor H Fortschr Neurol Psychiatr; 1991 Oct; 59(10):425-31. PubMed ID: 1662183 [TBL] [Abstract][Full Text] [Related]
23. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases. Sullivan EA; Staehling N; Philen RM J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159 [TBL] [Abstract][Full Text] [Related]
24. Eosinophilia-myalgia syndrome not associated with the ingestion of nutritional supplements. Clauw DJ; Flockhart DA; Mullins W; Katz P; Medsger TA J Rheumatol; 1994 Dec; 21(12):2385-7. PubMed ID: 7699648 [TBL] [Abstract][Full Text] [Related]
33. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique. Shapiro S J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181 [TBL] [Abstract][Full Text] [Related]
34. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases]. Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML Therapie; 1991; 46(5):355-65. PubMed ID: 1754978 [TBL] [Abstract][Full Text] [Related]
35. Head and neck manifestations of eosinophilia-myalgia syndrome. Levine B; Lanza DC; Ficco A; Freundlich B Ann Otol Rhinol Laryngol; 1995 Feb; 104(2):90-9. PubMed ID: 7857025 [TBL] [Abstract][Full Text] [Related]
36. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome. Silver RM; Sutherland SE; Carreira P; Heyes MP J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618 [TBL] [Abstract][Full Text] [Related]
37. The eosinophilia-myalgia syndrome: current concepts and future directions. Kaufman LD Clin Exp Rheumatol; 1992; 10(1):87-91. PubMed ID: 1551286 [TBL] [Abstract][Full Text] [Related]
38. Dyspnea and pulmonary function in the L-tryptophan-associated eosinophilia-myalgia syndrome. Read CA; Clauw D; Weir C; Da Silva AT; Katz P Chest; 1992 May; 101(5):1282-6. PubMed ID: 1582285 [TBL] [Abstract][Full Text] [Related]
39. Eosinophilia-myalgia syndrome: coming to grips with a new illness. Kilbourne EM Epidemiol Rev; 1992; 14():16-36. PubMed ID: 1289111 [TBL] [Abstract][Full Text] [Related]